215 related articles for article (PubMed ID: 10979074)
1. Hyperforin in extracts of St John's wort (Hypericum perforatum) for depression.
Vormfelde SV; Poser W
Arch Intern Med; 2000 Sep; 160(16):2548-9. PubMed ID: 10979074
[No Abstract] [Full Text] [Related]
2. St. John's Wort: is it effective and harmless?
Biron CR
RDH; 1999 Jun; 19(6):74-6. PubMed ID: 10895712
[No Abstract] [Full Text] [Related]
3. St John's Wort and literature quotations.
Mennini T; Gobbi M; Morazzoni P
Arch Intern Med; 2001 Apr; 161(7):1016-7. PubMed ID: 11295979
[No Abstract] [Full Text] [Related]
4. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
5. St. John's wort.
Lawvere S; Mahoney MC
Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
[TBL] [Abstract][Full Text] [Related]
6. St John's wort: Prozac from the plant kingdom.
Di Carlo G; Borrelli F; Ernst E; Izzo AA
Trends Pharmacol Sci; 2001 Jun; 22(6):292-7. PubMed ID: 11395157
[TBL] [Abstract][Full Text] [Related]
7. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
Schempp CM; Winghofer B; Lüdtke R; Simon-Haarhaus B; Schöpf E; Simon JC
Br J Dermatol; 2000 May; 142(5):979-84. PubMed ID: 10809859
[TBL] [Abstract][Full Text] [Related]
8. Hyperforin analogues from St. John's wort (Hypericum perforatum).
Verotta L; Appendino G; Jakupovic J; Bombardelli E
J Nat Prod; 2000 Mar; 63(3):412-5. PubMed ID: 10757735
[TBL] [Abstract][Full Text] [Related]
9. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
Ng QX; Venkatanarayanan N; Ho CY
J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
[TBL] [Abstract][Full Text] [Related]
10. Determining hyperforin and hypericin content in eight brands of St. John's wort.
de los Reyes GC; Koda RT
Am J Health Syst Pharm; 2002 Mar; 59(6):545-7. PubMed ID: 11908248
[No Abstract] [Full Text] [Related]
11. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants.
Klier CM; Schmid-Siegel B; Schäfer MR; Lenz G; Saria A; Lee A; Zernig G
J Clin Psychiatry; 2006 Feb; 67(2):305-9. PubMed ID: 16566628
[TBL] [Abstract][Full Text] [Related]
12. Current St John's wort research from mode of action to clinical efficacy.
Müller WE
Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
[TBL] [Abstract][Full Text] [Related]
13. Further degradation product of hyperforin from Hypericum perforatum (St John's Wort).
Vajs V; Vugdelija S; Trifunović S; Karadzić I; Juranić N; Macura S; Milosavljević S
Fitoterapia; 2003 Jul; 74(5):439-44. PubMed ID: 12837358
[TBL] [Abstract][Full Text] [Related]
14. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
Dimpfel W; Schober F; Mannel M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
[TBL] [Abstract][Full Text] [Related]
15. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort.
Buchholzer ML; Dvorak C; Chatterjee SS; Klein J
J Pharmacol Exp Ther; 2002 May; 301(2):714-9. PubMed ID: 11961077
[TBL] [Abstract][Full Text] [Related]
16. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
[TBL] [Abstract][Full Text] [Related]
17. Three new hyperforin analogues from Hypericum perforatum.
Shan MD; Hu LH; Chen ZL
J Nat Prod; 2001 Jan; 64(1):127-30. PubMed ID: 11170687
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John's Wort.
Kiewert C; Buchholzer ML; Hartmann J; Chatterjee SS; Klein J
Neurosci Lett; 2004 Jul; 364(3):195-8. PubMed ID: 15196674
[TBL] [Abstract][Full Text] [Related]
19. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.
Moore LB; Goodwin B; Jones SA; Wisely GB; Serabjit-Singh CJ; Willson TM; Collins JL; Kliewer SA
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7500-2. PubMed ID: 10852961
[TBL] [Abstract][Full Text] [Related]
20. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
